{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:14:04Z","timestamp":1767705244296,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cld.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T07:19:01Z","timestamp":1590909541000},"page":"437-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thrombocytopenia in Chronic Liver Disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Kathy M.","family":"Nilles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2020.04.009_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"17","key":"10.1016\/j.cld.2020.04.009_bib3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s40265-015-0480-0","article-title":"Management of thrombocytopenia in chronic liver disease: focus on pharmacotherapeutic strategies","volume":"75","author":"Maan","year":"2015","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2020.04.009_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199809103391107","article-title":"Thrombopoietin","volume":"339","author":"Kaushansky","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-8278(97)80291-7","article-title":"Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?","volume":"27","author":"Peck-Radosavljevic","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2020.04.009_bib7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/hep.510280535","article-title":"Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C","volume":"28","author":"Peck-Radosavljevic","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V95.3.795.003k25_795_801","article-title":"Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production","volume":"95","author":"Peck-Radosavljevic","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cld.2020.04.009_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2008.03674.x","article-title":"Review article: blood platelet number and function in chronic liver disease and cirrhosis","volume":"27","author":"Witters","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2020.04.009_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2013.03.040","article-title":"Coagulopathy in cirrhosis - the role of the platelet in hemostasis","volume":"59","author":"Tapper","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2020.04.009_bib14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.amjcard.2008.10.037","article-title":"Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation","volume":"103","author":"Sharma","year":"2009","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.cld.2020.04.009_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cgh.2010.06.018","article-title":"Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease","volume":"8","author":"Giannini","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib16","first-page":"513","article-title":"Potential applications of thromboelastography in patients with acute and chronic liver disease","volume":"8","author":"Stravitz","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1440-1746.2012.07246.x","article-title":"Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis","volume":"28","author":"Moussa","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2020.04.009_bib18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/MEG.0b013e328357d5f2","article-title":"Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports","volume":"24","author":"Voican","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.15280","article-title":"Romiplostim for the management of perioperative thrombocytopenia","volume":"182","author":"Al-Samkari","year":"2018","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/j.gastro.2013.10.012","article-title":"Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy","volume":"146","author":"Afdhal","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2011.01.020","article-title":"Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura","volume":"55","author":"Dultz","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","article-title":"Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia","volume":"155","author":"Terrault","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2020.04.009_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2014.07.007","article-title":"Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure","volume":"61","author":"Terrault","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"21","key":"10.1016\/j.cld.2020.04.009_bib25","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2169\/internalmedicine.8791-16","article-title":"Efficacy of repeated lusutrombopag administration for thrombocytopenia in a patient scheduled for invasive hepatocellular carcinoma treatment","volume":"56","author":"Sato","year":"2017","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12328-017-0735-2","article-title":"Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient","volume":"10","author":"Sakamaki","year":"2017","journal-title":"Clin J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2020.04.009_bib27","first-page":"1853","article-title":"Avoidance of platelet transfusion with readministration of lusutrombopag before radiofrequency ablation in hepatocellular carcinoma: a case report","volume":"114","author":"Kotani","year":"2017","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5387\/fms.2017-07","article-title":"Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization","volume":"63","author":"Fujita","year":"2017","journal-title":"Fukushima J Med Sci"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40265-015-0525-4","article-title":"Lusutrombopag: first global approval","volume":"76","author":"Kim","year":"2016","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","article-title":"A\u00a0randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation","volume":"54","author":"Tateishi","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.009_bib31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","article-title":"Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures","volume":"17","author":"Hidaka","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.009_bib32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2020.04.009_bib33","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/hep4.1423","article-title":"Thrombocytopenia and procedural prophylaxis in the era of thrombopoietin receptor agonists","volume":"3","author":"Nilles","year":"2019","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gie.2014.01.019","article-title":"Routine laboratory testing before endoscopic procedures","volume":"80","author":"Committee ASoP","year":"2014","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.cld.2020.04.009_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"Committee ASoP","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.cld.2020.04.009_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.gie.2012.03.252","article-title":"Adverse events of upper GI endoscopy","volume":"76","author":"Committee ASoP","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.cld.2020.04.009_bib37","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2020.04.009_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American association for the study of liver D. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American society of clinical Oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.009_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","article-title":"Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions","volume":"23","author":"Patel","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2020.04.009_bib43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/asheducation-2013.1.638","article-title":"Transfusion guidelines: when to transfuse","volume":"2013","author":"Szczepiorkowski","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jvir.2019.04.016","volume":"30","author":"Davidson","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"8","key":"10.1016\/j.cld.2020.04.009_bib45","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","volume":"30","author":"Patel","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.009_bib46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/liv.12038","article-title":"Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion","volume":"33","author":"Tripodi","year":"2013","journal-title":"Liver Int"},{"issue":"Supplement 2","key":"10.1016\/j.cld.2020.04.009_bib47","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(12)60101-9","article-title":"Single use of romiplostim thrombopoietin analogue in severe thrombocytopenia for outpatient percutaneous liver biopsy in patients with chronic liver disease--a randomized double blinded prospective trial","volume":"56","author":"Basu","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.009_bib48","first-page":"1254A","article-title":"Lusutrombopag for treatment of thrombocytopenia in patients with chronic liver disease who are undergoing non-emergency invasive procedures: results from an international phase 3, randomized, double-blind, placebo-controlled study (L-PLUS-2)","volume":"66","author":"Afdhal","year":"2017","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:07Z","timestamp":1761069367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326120300349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1089326120300349"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.009","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytopenia in Chronic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}